Distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 12, 2000, Pages 2670-2676

  Asztalos, Bela F ^a,b   Roheim, Paul S ^c   Milani, Richard L ^d   Lefevre, Michael ^e   McNamara, Judith R ^a,b   Horvath, Katalin V ^a,b   Schaefer, Ernst J ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^d Ochsner for Children   (United States)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Apolipoproteins; Coronary heart disease; HDL subpopulations; Lipids; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033670164     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.12.2670     Document Type: Article

References (45)

1. Cholesterol and mortality: 30 Years of follow-up from the Framingham Study
2. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults
3. Triglyceride, high-density lipoprotein and coronary heart disease
4. High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study
5. High-density lipoprotein cholesterol and coronary heart disease, cardiovascular disease, and all-cause mortality
6. The Tromso Heart Study: High-density lipoprotein and coronary heart disease: A prospective case-control study
7. High-density lipoprotein cholesterol and incidence of coronary heart disease: The Israel Ischemic Heart Disease Study
8. High-density lipoprotein cholesterol and myocardial infarction or sudden coronary death: A prospective case-control study in middle-aged men of the Oslo study
9. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
10. Prediction of coronary heart disease using risk factor categories
11. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: A 21-year follow-up of 8000 men
12. Different reactivities of high-density lipoprotein2 subfractions with hepatic lipase
13. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein
14. Regulation of the concentration of preβ high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity
15. Physiological role and clinical relevance of high density lipoprotein subclasses
16. Altered properties of high density lipoprotein subfractions in obese subjects
17. Two-dimensional electrophoresis of plasma lipoproteins: Recognition of new apo A-I-containing subpopulations
18. Normolipidemic subjects with low HDL cholesterol levels have altered HDL snbpopulations
19. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis
20. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects
21. Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics
22. Apolipoprotein A-I containing lipoproteins in coronary artery disease
23. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction
24. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: The ECTIM Study
25. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apoli poprotein A-I and A-II, with coronary stenosis and left ventricular function
26. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: Results of NHLBI Type II Coronary Intervention Study
27. Decreased HDL2 and HDL3 cholesterol, apoA-I and apoA-II, and increased risk of myocardial infarction
28. Associations of HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men
29. Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia
30. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease
31. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol
32. Estimation of the concentration of low density 4 cholesterol in plasma without use of the ultracentrifuge
33. Autoradiography using storage phosphor technology
34. Protein-lipid relationship in human plasma in atherosclerosis and related conditions
35. High-density lipoprotein as a predictor of clinical coronary heart disease
36. New aspect in the prediction of coronary artery disease: The Prospective Cardiovascular Munster Study
37. Plasma apolipoprotein A-I absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease
38. Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis
39. High density lipoprotein cholesterol, plasma triglyceride, and coronary heart disease: Pathophysiology and management
40. High-density lipoprotein metabolism
41. Apolipoprotein A-containing lipoprotein particles: Physiological role, quantification, and clinical significance
42. High density lipoprotein subfractions
43. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk: The PROCAM experience and pathophysiological implications for reverse cholesterol transport
44. Subclasses of LpA-I in coronary artery disease: Distribution and cholesterol efflux ability